Form 8-K - Current report:
SEC Accession No. 0001628280-25-010422
Filing Date
2025-03-05
Accepted
2025-03-05 16:13:14
Documents
27
Period of Report
2025-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20250305.htm   iXBRL 8-K 31320
2 EX-99.1 aqst-q424xex991earningsrel.htm EX-99.1 261539
3 EX-99.2 q42024supplementalearnin.htm EX-99.2 18068
7 aqstlogo.jpg GRAPHIC 14528
8 q42024supplementalearnin001.jpg GRAPHIC 104009
9 q42024supplementalearnin002.jpg GRAPHIC 296951
10 q42024supplementalearnin003.jpg GRAPHIC 145155
11 q42024supplementalearnin004.jpg GRAPHIC 78712
12 q42024supplementalearnin005.jpg GRAPHIC 78278
13 q42024supplementalearnin006.jpg GRAPHIC 128775
14 q42024supplementalearnin007.jpg GRAPHIC 118257
15 q42024supplementalearnin008.jpg GRAPHIC 81729
16 q42024supplementalearnin009.jpg GRAPHIC 92837
17 q42024supplementalearnin010.jpg GRAPHIC 87788
18 q42024supplementalearnin011.jpg GRAPHIC 30873
  Complete submission text file 0001628280-25-010422.txt   2199980

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20250305.xsd EX-101.SCH 1776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20250305_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20250305_pre.xml EX-101.PRE 12504
29 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20250305_htm.xml XML 2719
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 25711146
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)